Helicobacter pylori Antibody Kit for Use on Automated Chemistry Analyzers
Helicobacter pylori colonizes in human gastric mucosa and causes chronic gastritis. It is well established that progression of inflammation leads to gastric mucosal atrophy and gastric cancer. The International Agency for Research on Cancer has recognized that H. pylori is a cause of gastric cancer and that eradication of H. pylori is a preventive measure for gastric cancer.
- Measured by latex-enhanced turbidimetric immunoassay.
- Measurements are made from serum or plasma specimens using general purpose automated analyzers, which can help stratify gastric cancer risk when judged together with the pepsinogen assessment.
- A large number of specimens can be processed in a short time.
- Reactivity is good due to the use of antigens obtained from an isolate from a Japanese patient (East Asian genotype).
- High sensitivity is expected to reduce false negative diagnoses and is effective for stratifying gastric cancer risk.
To detect anti-Helicobacter pylori antibodies in serum or plasma (Assists in the diagnosis of Helicobacter pylori infection, etc.)
3 to 100 U/mL (In-house data)＊
＊May vary depending on the automated analyzer used and parameters set
Result assessment method
Set the cutoff value to 10 U/ml
10 U/ml and more indicates positive, and less than 10 U/ml indicates negative